Document Type
Article
Publication Date
8-7-2021
Abstract
Ischemic bowel disease (ISBODI) includes colon ischemia, acute mesenteric ischemia (AMI) and chronic mesenteric ischemia (CMI). Epidemiologically, colon ischemia is the most common type followed by AMI and CMI. There are various risk factors for the development of ISBODI. Abdominal pain is the common presenting symptom of each type. High clinical suspicion is essential in ordering appropriate tests. Imaging studies and colonoscopy with biopsy are the main diagnostic tests. Treatment varies from conservative measures to surgical resection and revascularization. Involvement of multidisciplinary team is essential in managing ISBODI. Although open surgery with revascularization plays an important role, recently there is an increasing interest in percutaneous endovascular treatment.
Recommended Citation
Ahmed, Monjur, "Ischemic bowel disease in 2021" (2021). Division of Gastroenterology and Hepatology Faculty Papers. Paper 71.
https://jdc.jefferson.edu/gastro_hepfp/71
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial 4.0 License
Language
English
Comments
This article is the author’s final published version in World Journal of Gastroenterology, August 2021, Volume 27, Issue 29, Pages 4746 - 4762.
The published version is available at https://doi.org/10.3748/wjg.v27.i29.4746. Copyright © Ahmed.